Sign in to view content

RGX-314 for Neovascular AMD: Ongoing Phase I/IIa Results for Cohorts 1-5

Arshad M. Khanani, MD, MA, FASRS

Video
Published 2020

Related

An Assessment of the Impact of Disease Activity Criteria on Dosing Interval Assignment in Clinical Trial Patients With nAMD
Marco A. Zarbin, MD, PhD
Annual Meeting Talks
2023
Phase 1/2 Clinical Trial of Intravitreal 4D-125 AAV Gene Therapy in Patients with Advanced XLRP: Interim Safety & Preliminary Activity
Cagri G Besirli, MD, PhD, FASRS
Updates from the Field
2021
Comparison of CRISPR-based Genome Editing of VEGF-A as Treatment Strategy for Choroidal Neovascularization
Glenn C. Yiu, MD, PhD
Updates from the Field
2019

Category: AMD-Neovascular

See more